| MASLD. | Metabolic dysfunction-associated steatotic liver disease |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| MASH | metabolic dysfunction-associated steatohepatitis |
| ALT | Alanine aminotransferase |
| NHANES | National Health and Nutrition Examination Survey |
| HH | Household |
| MRI | Magnetic resonance imaging |
| SDI | Socio-Demographic Index |
| DALYs | disability-adjusted life years |
| NAS | NAFLD Activity Score |
| FLI | Fatty Liver Index |
| SCFAs | Short-chain fatty acids |
| FXR | Farnesoid X receptor |
| TGR5 | Takeda G protein-coupled receptor 5 |
| Adipo-IR | Adipose tissue insulin resistance |
| IR | Insulin Resistance |
| CGM | Continuous Glucose Monitoring |
| OSA | Obstructive sleep apnea |
| CPAP | Continuous positive airway pressure |
| BMD | Bone mineral density |
| BMI | Body mass Index |
| GFR | Glomerular filtration rate |
| NITs | Non-invasive tests |